ATP861 发表于 2025-3-25 06:15:09

The Role of Ablative Therapies in Renal Cancer,ablative therapies compared to partial nephrectomy (PN), however, as no randomized control trial exists, there is often selection bias. Cancer specific survival (CSS) and disease free survival (DFS) have been comparable for thermal ablative techniques. Local recurrence rates are higher for thermal a

Needlework 发表于 2025-3-25 07:36:46

http://reply.papertrans.cn/83/8270/826980/826980_22.png

Abutment 发表于 2025-3-25 13:01:07

http://reply.papertrans.cn/83/8270/826980/826980_23.png

争论 发表于 2025-3-25 18:58:20

http://reply.papertrans.cn/83/8270/826980/826980_24.png

土产 发表于 2025-3-25 20:57:25

Lymph Node Dissection in Renal Cancer and Upper Tract Urothelial Cancer,y advanced disease and may be of therapeutic benefit in some patients. Several retrospective studies support the hypothesis that LND may be beneficial in high risk patients such as clinical T3-T4, high grade, those with sarcomatoid features or coagulative tumour necrosis. A subset of patients with p

Alpha-Cells 发表于 2025-3-26 02:58:16

http://reply.papertrans.cn/83/8270/826980/826980_26.png

使混合 发表于 2025-3-26 05:23:42

Ryan L. Steinberg,Brett A. Johnson,Jeffrey A. Cadeddu,Abhay Rane

Aspiration 发表于 2025-3-26 10:38:46

Eduard Roussel,Mattias Willem van Hattem,Maarten Albersen,Steven Joniau,Hendrik Van Poppel

Jingoism 发表于 2025-3-26 13:27:38

http://reply.papertrans.cn/83/8270/826980/826980_29.png

同步左右 发表于 2025-3-26 19:33:51

http://reply.papertrans.cn/83/8270/826980/826980_30.png
页: 1 2 [3] 4 5 6 7
查看完整版本: Titlebook: Renal Cancer; Current Status and I Christopher Anderson,Mehran Afshar Book 2022 Springer Nature Switzerland AG 2022 Endoscopic Surgery.Cogn